Loading…
Loading…
MAPT does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for MAPT and 80,000+ other tickers.
See exactly how MAPT's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for MAPT and 80,000+ other tickers.
Maptelligent, Inc. delivers a cutting-edge cloud-based geographic platform designed to centralize and process critical data. This platform seamlessly integrates diverse information from sources such as sensors, cameras, alarms, and access control systems, transforming it into clear, actionable intelligence presented on an intuitive map interface. It provides essential information about structures and sites, significantly boosting situational awareness and optimizing emergency response both while first responders are en route and upon their arrival at an incident. This ultimately helps to…
[url="]Ionis Pharmaceuticals, Inc.[/url] (Nasdaq: IONS) today announced that its partner, Biogen, shared data from the Phase 2 CELIA study evaluating diranerse
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-MAPT, the company's investigational RNA interference (RNAi) therapeutic being developed as a potential treatment for tauopathies including Alzheimer's disease, a progressive neurodegenerative disease characterized by cognitive and functional decline. Alzheimer's disease is the most common cause of dementia, affecting an esti.
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has filed a request for regulatory clearance to initiate a Phase 1/2a clinical trial of ARO-MAPT, the company's investigational RNA interference (RNAi) therapeutic being developed as a potential treatment for tauopathies including Alzheimer's disease, a progressive neurodegenerative disease characterized by cognitive and functional decline. Alzheimer's disease is the most common cause of de.
LAS VEGAS, NV, Dec. 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Maptelligent, Inc., (OTC PK: MAPT) www.maptelligent.com – Axim Geospatial is to provide Maptelligent complete GIS services with indoor map applications as part of its building information solution set. Axim Geospatial will manage building data and provide customized services using Esri products, scanning, Building Information Modeling (BIM), photogrammetry, project management applications, and asset management applications. Maptelligent continues its dedication to bringing the latest in custom configured, geo-enabled, indoor mapping applications to the market. The integrated solutions provide the latest in disparate data interoperability and real-time actionable intelligence to customers on their operations. Mr. Joseph Cosio-Barron, CEO for Maptelligent, Inc., says, “This agreement with the Axim Geospatial, an Esri Platinum business partner, allows Maptelligent to continue to enhance and advance our GIS enabled digital twin solutions with critical data and information for better digital management of buildings, assets and objects.” Mr. Kevin Stewart, VP Sales for Axim Geospatial, stated, “Axim is excited to partner with Maptelligent on this project as helping organizations harness the power of indoor location technology and digital twin capabilities to deliver value-driven solutions continues to be a focus for Axim.”
LAS VEGAS, NV, Feb. 23, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Maptelligent, Inc., (OTC PK: MAPT) www.maptelligent.com, its where indoor maps become intelligent. Maptelligent, Inc., has a new strategic focus, implementing innovative technology, allowing customers to model their operations and solve today's complex business problems. Using the latest in remote capture technology (LIDAR, Photogrammetry), building information, modeling and location intelligence delivers customized digital twin and Industry 4.0 applications. Maptelligent, Inc., a Silver Partner in the Esri Partner Network (EPN), provides customers a secure web application with a flexible framework on Esri's ArcGIS Platform technology. Maptelligent, Inc., provides web and mobile solutions that leverage the latest in Esri's no code/low code development capability. This provides cost effective, customized solutions, which are tailored to our customers' unique disparate data and operational requirements. Coupled with Esri's ArcGIS GeoBIM and Autodesk Construction Cloud interoperability, the Maptelligent, Inc., Explorer solution delivers an innovative, easy-to-use web-based experience by integrating multiple operations, including asset management, building automation and control, interdisciplinary coordination, scheduling, cost estimating, and integrated construction specifications.